Trials / Unknown
UnknownNCT00370669
Effect of Intravitreal Bevacizumab on Clinically Significant Macular Edema
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 150 (planned)
- Sponsor
- Shahid Beheshti University of Medical Sciences · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
to compare the effect of intravitreal bevacizumab alone or in combination with triamcinolone acetonide with laser photocoagulation on clinically significant macular edema (CSME)
Detailed description
we entered 150 eyes into the study that recruitment of cases finished recently.Eligible eyes randomly assign to one of the study arms including intravitreal bevacizumzb, intravitreal bevacizumzb/triamcinolone and macular photocoagulation groups. Every patient needs at least 1 year followup. During this time BCVA, OCT, FA will be done for each patient and inaccording to interpretation of datas and fundus exam repeatation of injection will be done.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | bevacizumab | |
| DRUG | triamcinolone acetonide |
Timeline
- Start date
- 2005-11-01
- Completion
- 2007-02-01
- First posted
- 2006-09-01
- Last updated
- 2007-02-22
Locations
1 site across 1 country: Iran
Source: ClinicalTrials.gov record NCT00370669. Inclusion in this directory is not an endorsement.